Search results
From Self-sufficiency
Page title matches
Page text matches
-
67 KB (9,844 words) - 20:17, 21 September 2010
-
177 KB (19,269 words) - 21:05, 21 September 2010
-
71 KB (10,445 words) - 21:05, 21 September 2010
-
39 KB (4,237 words) - 21:06, 21 September 2010
-
43 KB (4,797 words) - 21:06, 21 September 2010
-
37 KB (3,368 words) - 21:07, 21 September 2010
-
7 KB (1,011 words) - 21:25, 21 September 2010
-
13 KB (1,758 words) - 21:27, 21 September 2010
- ...ted with prostaglandin-mediated side effects which have been reported with COX-2 inhibitors and NSAIDs, such as GI bleeding, renal insufficiency, cardiovasc796 bytes (102 words) - 22:04, 21 September 2010
- ...tematic review of adverse renal and arrhythmia risk of valdcoxib and other COX-2 inhibitors, JAMA 2006] [[Category:COX-2 inhibitors]]6 KB (784 words) - 22:05, 21 September 2010
- ===COX-2 inhibitors=== {{Main|COX-2 inhibitor}}14 KB (1,807 words) - 22:06, 21 September 2010
- [[Category:COX-2 inhibitors]]841 bytes (99 words) - 22:07, 21 September 2010
-
30 KB (4,151 words) - 22:14, 21 September 2010
-
16 KB (2,012 words) - 22:15, 21 September 2010
- ...intestinal side effects of NSAIDs like aspirin. In practice, use of some [[COX-2 inhibitor]]s with their [[Adverse drug reaction|adverse effects]] has led t ...he identification of increased risks of heart attacks with the selective [[COX-2 inhibitor]] [[rofecoxib]] in 2004, attention has focused on all the other m28 KB (3,886 words) - 22:16, 21 September 2010
- ...NSAID properties is unknown, but it is thought to act on enzymes COX-1 and COX-2, inhibiting prostaglandin synthesis.5 KB (722 words) - 22:16, 21 September 2010
- ...been shown, especially at its low therapeutic dose, selectively to inhibit COX-2 over COX-1.<ref name = noble>{{cite journal | last7 = Distel}}</ref> and perhaps all other NSAIDs which are not COX-2 selective.<ref name = hawkey>{{cite journal11 KB (1,540 words) - 22:16, 21 September 2010
- ...hibit COX-1 and are designated as having "preferential selectivity" toward COX-2. Interestingly, the (inactive against COX) r-enantiomer of etodolac inhibit8 KB (1,051 words) - 22:16, 21 September 2010
- ...i-inflammatory properties by inhibiting cyclooxygenase-1 and -2 (COX-1 and COX-2) enzymes reversibly, which decreases production of pro-inflammatory prostag11 KB (1,457 words) - 22:16, 21 September 2010
-
3 KB (375 words) - 22:16, 21 September 2010